CKS1B and familial pancreatic carcinoma: And wound healing assays illustrated that the migratory rate of SW1990 cells with shCKS1B transfection was 13.09 ± 0.37%, lower than that control group 31.32 ± 0.66%, which implied that CKS1B enhanced the migratory capacity of pancreatic cancer cells (Figure 9D).